📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
5 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
6
IONS Latest News & AI Sentiment Analysis
5 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 7 ARTICLES
TimesSquare Mid Cap Growth Strategy Picks Ionis Pharmaceuticals Inc. (IONS) on Clinical Momentum
Ionis Pharmaceuticals (IONS) has been identified as a core holding within TimesSquare Capital Management's mid-cap growth strategy, with...
TimesSquare Mid Cap Growth Strategy Picks Ionis Pharmaceuticals (IONS) on Clinical Momentum
Ionis Pharmaceuticals (IONS) has been selected by TimesSquare Capital Management's U.S. Mid Cap Growth Strategy, reflecting...
Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction - Slideshow (NASDAQ:IONS) 2026-06-25
IONS has secured FDA approval for TRYNGOLZA, a potentially market-shifting therapeutic targeting severe hypertriglyceridemia with acute...
Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction Transcript
IONS has secured FDA approval for TRYNGOLZA, marking a significant commercial milestone in the treatment of severe hypertriglyceridemia...
Is lonis Pharmaceuticals, Inc. (IONS) Among the Best Genomics Stocks to Buy According to Analysts?
IONS has been highlighted among top genomics equities following a positive Phase 3 data readout for bepirovirsen, a partnership program...
Ionis Pharmaceuticals, Inc. (IONS) Presents at National Lipid Association (NLA) 2026 Scientific Sessions - Slideshow (NASDAQ:IONS) 2026-06-15
Ionis Pharmaceuticals (IONS) presented research findings at the National Lipid Association's 2026 Scientific Sessions, a routine...
Ionis Pharmaceuticals, Inc. (IONS) Presents at Endocrine Society's Annual Meeting (ENDO 2026) - Slideshow (NASDAQ:IONS) 2026-06-15
IONS presented clinical or pipeline data at the Endocrine Society's Annual Meeting (ENDO 2026), a standard industry conference....
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice